FLAIR

(Recruiting)

 Front-Line therapy in CLL: Assessment of Ibrutinib+ Rituximab  
B029448

(Recruiting)

 A Multicenter, Double-Blond, Randomized, and Placebo-Controlled Phase IbStudy Evaluating the Safety of Adding Tocilizumab to Standard Premedications Prior to Administration of Obinutuzumab in Combination with Chlorambucil in Patients with Previously Untreated B-Cell Chronic Lymphocytic Leukemia and Comorbidities